Search Keywords

Results Restricted To:

https://www.temple.edu

Total Results: 15

Admissions - Temple University

https://www.temple.edu/admissions

Explore Temple Admissions Learn more about applying for one of our undergraduate, graduate or professional programs and discover financial aid and scholarship opportunities.

Biologics and Biosimilars Manufacturing Certificate (Graduate)

https://www.temple.edu/academics/degree-programs/biologics-biosimilars-manufacturing-certificate-graduate-ph-bbmn-grad

Temple’s Certificate in Biologics and Biosimilars Manufacturing focuses on chemistry, manufacturing and controls aspects in the development and manufacture of these products, preparing students for positions in the biopharmaceutical industry and sharpening the skills and knowledge of those already working in this field.

Wireshark_TCP.pdf - Temple University

https://cis.temple.edu/~tug29203/18spring-3329/reading/Lab_7_Solutions.pdf

The answers below are based on the trace file tcp-ethereal-trace-1 in in

Biotech entrepreneur and vaccine leader Charles Tsan-Jian Chen to ...

https://cst.temple.edu/news/2023/05/biotech-entrepreneur-vaccine-leader-charles-tsan-jian-chen-receive-honorary-degree-cst-graduation-ceremony

Charles Tsan-Jian Chen, a world leader and entrepreneur in the biotech industry with more than four decades of accomplishments in developing, producing and implementing forefront vaccine and diagnostic technologies benefiting human and animal health, will be awarded an honorary doctoral degree from Temple University at the College of Science and Technology's graduation ceremony on Friday, May ...

Novel Gene-Editing Strategy Leverages Unusual Genetic Alteration to ...

https://www.templehealth.org/about/news/novel-gene-editing-strategy-leverages-unusual-genetic-alteration-to-block-hiv-spread-in-cells

Genetic alterations that give rise to a rare, fatal disorder known as MOGS-CDG paradoxically also protect cells against infection by viruses. Now, Temple scientists have harnessed this unusual protective ability in a novel gene-editing strategy aimed at eliminating HIV-1 infection.